quadrivalent neoantigen vaccine(Weill Cornell Medicine)

N/A

Report date: 2025/01/26 16:50:50

Base Information

Drug Namequadrivalent neoantigen vaccine(Weill Cornell Medicine)

Drug Alias Namecolorectal tumor vaccine (Weill Medical College of Cornell University)

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideBiologics > Antigen > Tumor antigen +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWeill Medical College of Cornell University

China Registration ClassN/A

Develop Information

Active CompaniesWeill Medical College of Cornell University

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A